The association of serum lipids and inflammatory biomarkers with renal function in men with type II diabetes mellitus
- PMID: 16408124
- PMCID: PMC1630638
- DOI: 10.1038/sj.ki.5000021
The association of serum lipids and inflammatory biomarkers with renal function in men with type II diabetes mellitus
Abstract
Dyslipidemia and inflammation may promote renal disease via mechanisms of vascular endothelial cell dysfunction in type II diabetes mellitus (DM). Sparse data, however, are available on the relation of lipids and inflammatory biomarkers and glomerular filtration rate (GFR) in type II DM. We performed a cross-sectional study of 732 men with type II DM enrolled in the Health Professionals' Follow-Up Study. Plasma creatinine was used to estimate GFR by the simplified Modification of Diet in Renal Disease (MDRD) equation. In men with a GFR <60 ml/min/1.73 m(2), triglycerides, non-high-density lipoprotein (HDL), apoprotein B, fibrinogen, soluble tumor necrosis factor receptor (sTNFR-2) and vascular cell adhesion molecule-1 (VCAM) were significantly higher when compared to the referent group (GFR> or =90 ml/min/1.73 m(2)). In multivariable logistic regression, those in the highest quartiles of the following biomarkers had increased odds of having a GFR <60 ml/min/1.73 m(2) when compared to those in the lowest quartiles: triglycerides (odds ratio (OR) 3.11; 95% CI, 1.52-6.36), fibrinogen (OR 5.40; 95% CI 2.14-13.65), sTNFR-2 (OR 8.34; 95% CI 3.50-19.88) and VCAM (OR 4.50; 95% CI 1.98-10.23). An inverse association was observed for HDL (OR 0.48; 95% CI 0.24-0.98). We found no association between C-reactive protein and GFR. The results were similar when creatinine clearance by Cockcroft-Gault was used to estimate kidney function. We conclude that several potentially modifiable lipid and inflammatory biomarkers are elevated in the setting of moderately decreased GFR in men with type II DM and may be the link between renal insufficiency and increased risk for cardiovascular events in this population.
Comment in
-
Inflammation and dyslipidemia in nephropathy: an epidemiologic perspective.Kidney Int. 2006 Jan;69(2):206-8. doi: 10.1038/sj.ki.5000111. Kidney Int. 2006. PMID: 16408107
Similar articles
-
The association of serum lipids with renal function: the Korea Medical Institute Study.Eur J Cardiovasc Prev Rehabil. 2009 Feb;16(1):60-5. doi: 10.1097/HJR.0b013e32831de248. Eur J Cardiovasc Prev Rehabil. 2009. PMID: 19188811
-
Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study.J Am Soc Nephrol. 2006 Feb;17(2):537-45. doi: 10.1681/ASN.2005080834. Epub 2005 Dec 28. J Am Soc Nephrol. 2006. PMID: 16382015
-
Crosstalk of inflammatory mediators and lipid parameters as early markers of renal dysfunction in stable renal transplant recipients with regard to immunosuppression.Ann Transplant. 2013;18:414-23. doi: 10.12659/aot.889239. Ann Transplant. 2013. PMID: 23946969
-
Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes.Clin J Am Soc Nephrol. 2009 Jan;4(1):62-70. doi: 10.2215/CJN.03010608. Epub 2008 Dec 10. Clin J Am Soc Nephrol. 2009. PMID: 19073786 Free PMC article.
-
The role of inflammation as a pathogenic factor in the development of renal disease in diabetes.Curr Diab Rep. 2005 Dec;5(6):399-401. doi: 10.1007/s11892-005-0044-x. Curr Diab Rep. 2005. PMID: 16316588 Review. No abstract available.
Cited by
-
Cilostazol effectively attenuates deterioration of albuminuria in patients with type 2 diabetes: a randomized, placebo-controlled trial.Endocrine. 2014 Mar;45(2):293-301. doi: 10.1007/s12020-013-0002-3. Epub 2013 Jun 18. Endocrine. 2014. PMID: 23775007 Clinical Trial.
-
Tumor necrosis factor (TNF-alpha) and C-reactive protein (CRP) are positively associated with the risk of chronic kidney disease in patients with type 2 diabetes.Yonsei Med J. 2010 Jul;51(4):519-25. doi: 10.3349/ymj.2010.51.4.519. Yonsei Med J. 2010. PMID: 20499416 Free PMC article.
-
Tumor necrosis factor receptors 1 and 2 are associated with early glomerular lesions in type 2 diabetes.Kidney Int. 2016 Jan;89(1):226-34. doi: 10.1038/ki.2015.278. Epub 2016 Jan 4. Kidney Int. 2016. PMID: 26398493 Free PMC article.
-
Should we use statins in all patients with chronic kidney disease without dialysis therapy? The current state of knowledge.Int Urol Nephrol. 2015 May;47(5):805-13. doi: 10.1007/s11255-015-0937-9. Epub 2015 Mar 11. Int Urol Nephrol. 2015. PMID: 25758011 Review.
-
Association of C-Reactive Protein and Other Markers of Inflammation with Risk of Complications in Diabetic Subjects.EJIFCC. 2006 Mar 20;17(1):8-11. eCollection 2006 Mar. EJIFCC. 2006. PMID: 29795716 Free PMC article.
References
-
- Bolton CH, Downs LG, Victory JG, et al. Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines. Nephrol Dial Transplant. 2001;16:1189–1197. - PubMed
-
- Mezzano D, Pais EO, Aranda E, et al. Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia. Kidney Int. 2001;60:1844–1850. - PubMed
-
- Papayianni A, Alexopoulos E, Giamalis P, et al. Circulating levels of ICAM-1, VCAM-1, and MCP-1 are increased in haemodialysis patients: association with inflammation, dyslipidaemia, and vascular events. Nephrol Dial Transplant. 2002;17:435–441. - PubMed
-
- Shlipak MG, Fried LF, Crump C, et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation. 2003;107:87–92. - PubMed
-
- Schaeffner ES, Kurth T, Curhan GC, et al. Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol. 2003;14:2084–2091. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials